| Name | Title | Contact Details |
|---|
Metsera is a clinical-stage biopharmaceutical company based in New York City, dedicated to developing innovative treatments for obesity and metabolic diseases. Founded in 2022 by Population Health Partners and ARCH Venture Partners, the company has raised $290 million from prominent healthcare investors to support its research and development initiatives. Metsera is advancing a diverse portfolio of oral and injectable therapies, including incretin, non-incretin, and combination treatments. These therapies target various aspects of weight loss and are developed from a proprietary library of over 20,000 gut hormone peptides and peptide/antibody conjugates. A notable partnership with Amneal Pharmaceuticals focuses on the development and supply of its investigational weight loss therapy, MET-097.
Wesfield Construction Co Inc is a West Chesterfield, NH-based company in the Business Services sector.
Marr Roy Group is a Mississauga, ON-based company in the Business Services sector.
African Metals Corporation is a Vancouver, BC-based company in the Business Services sector.
Dataedo is a lightweight data cataloging tool built to serve as a single source of truth about your data.